Introduction
Influenza is a highly contagious, respiratory tract infection that affects most of the world's population annually, especially, in Asia. Although the infection is considered to be a self-limiting disease, influenza is in fact associated with considerable morbidity and mortality worldwide, affecting all age groups. Indeed, adults >65 years of age currently account for ;90% of all influenza-related mortality (1) . Studies have pointed out that the risk of influenza-related hospitalization is also high in healthy young children, especially in those aged <5 years (2) .
It is generally thought that many infections are handled successfully by the innate immune system and cause no disease; others that cannot be resolved by innate immunity trigger an adaptive immune response and are then overcome successfully, followed by lasting immunological memory (3) . Monocytes including dendritic cells (DCs) are well-recognized and important constituents of the innate immune system. DCs take up process and present antigens to T cells and produce cytokines that influence the innate and adaptive immune responses (4, 5) . How the innate immune system contributes to defense of influenza virus infection and what the behavioral differences between monocytes and CTL in their killing processes remains unknown.
Influenza virus can be controlled by CD8 T cells or by antibodies (5, 6) . CTL combat influenza viral infections by recognizing and destroying virus-infected host cells that become the factories for viral replication. Infected cells expressing the MHC I-viral peptide complex on their surfaces are recognized by activated virus-specific CTL (7) . Granule-mediated killing is particularly important for the control of respiratory viral infections (8) . In a process involving Perferin (Perf) and granule-mediated killing, granzymes are transported across the cell membrane into the cytoplasm of the target cell and are involved in an enzymatic cascade that eventually results in DNA fragmentation and cell death (apoptosis) (5, (9) (10) (11) .
Cell-mediated CD8 T cell response is generally thought to contribute to the control of virus infection (6, 12) . Memory T cells can be classified into two distinct populations with distinct lymph node homing properties, anatomical locations and function: the CD62L high 'central memory' (T CM ) and CD62L
low 'effector memory' (T EM ) (13) . There is much debate about how the T CM and T EM subsets relate to each other (14) (15) (16) (17) . Early studies showed that naive CD8
+ cells primed by an interaction with antigen-presenting cells scarring high levels of antigen and co-stimulatory molecules undergo up to eight cell divisions and differentiate to effectors. This implies that CD62L expression would drop from T CM to T EM . CD62L
low T EM cells have a low proliferation capacity (18) . Actually, the conversion between CD62L
high and CD62L
low
T cells was never directly demonstrated (19) . Recent studies showed that the T CM and T EM are distinct cell lineages.
If the T CM and T EM are different cell lineages, what is the function of T CM ?
Human PBMC stimulated with virus can kill autologous PBMC that had been stimulated with plant lectins such as PHA to keep the cells alive and then infected with virus (20) . Since PBMC are mainly involved in immune system responses, these cytotoxicity assays indicated that influenza virus could infect these immune cells and the infected cells could be killed by effector cells. Current knowledge states that a virus-infected cell must be producing viral peptides and displaying them on the surface of the cell in order to be recognized by cytotoxic immune cells. However, this simplistic understanding of the interaction between the immune system and the influenza virus hardly explains how the immune system clears itself of infection. Can the human immune system directly remove free virus? Furthermore, it is most important to understand why the influenza virus infection often causes secondary infection. Therefore, it is necessary to develop a better understanding of the immune mechanisms that are linked to influenza virus infection. This paper presented the evidence that influenza virus infection immediately provoked the response of the innate and adaptive immune system. Virus infection produced the increase of granzyme B (GrB) expression in monocytes, activated T and B lymphocytes. Hence, they gained cytolytic function. Infected PBMC can be killed or going to apoptosis, which might be the mechanism of combating virus infection and the secondary infection caused by viral infection.
Methods

Human subjects and virus
Sixty healthy adult (age range 20-74, mean 45) volunteers were recruited into this study through written informed consent. The institutional review board approved the protocol and informed consent document. Influenza virus strains: A/Wyoming/03/2003 (H3N2) was given from the Dr Adolfo Garcia-Sastre.
Preparation of human PBMC and stimulation
Human peripheral blood was collected in heparinized tubes from donors. Human PBMC were prepared by Histopaque-1077 (Sigma-Aldrich), washed with PBS one time, treated with RBC Lysis Solution (pH 7.3, 155 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA) for 5 min to remove red blood cells, washed and then re-suspended in AIM-V media (Gibco Laboratories, Grand Island, NY, USA) and adjusted to 2.0 3 10 6 ml À1 . One milliliter of suspended cells were added into each well of a 48-well multiplate (Nalge Nunc), stimulated with influenza virus using a multiplicity of infection (MOI) = 2 (4 3 10 6 ml À1 TCID 50 ml
À1
) and incubated in a humidified atmosphere at 37°C in 5% CO 2 . The concentration of PHA was 1 lg ml À1 AIM-V media. Influenza protein was prepared from flu vaccine (2007-08). Stimulation used 2 lg ml À1 in AIM-V. All cells were collected through repeating to deliver and contain with 1 ml pipetter and washed with PBS without calcium.
Assay of apoptosis
Apoptotic DNA fragment assay used Roche DNA-Fragment Kit. Annexin-V and propidium iodide (PI) staining used Apoptosis Annexin-V Kit II (BD).
Antibodies and flow cytometry
The following antibodies used for flow cytometry were purchased from BD Pharmingen: anti-CD8-Percp, anti-CD19-Percp, anti-Perf-PE, anti-CD62L-allophycoerythrin, anti-CD11c-PE, anti-CD107b-FITC, anti-GrB and anti-CD107a-PE antibodies. In addition, Mouse isotype IgG-FITC, Mouse isotype IgG-PE, Mouse isotype IgG-allophycoerythrin, anti-CD14-PE, anti-CD138-PE and anti-CD3-PE-Cy7 antibodies were purchased from eBioscience. BD cell fixing and permeabilization solution was used for intracellular staining (Perf, GrB). Data were acquired on the BD LSR II and analyzed using Flow Jo software (Tree Star, Ashland, OR, USA). Virus re-challenging one milliliter of 2 3 10 6 ml À1 PBMC-suspended cells were stimulated with influenza virus A/Wyoming/03/2003 (H3N2) (MOI = 2) for 5 days and then collected, washed with PBS one time, re-suspended in 1 ml AIM-V medium containing 1 lg ml À1 anti-CD107a or anti-CD107b antibody and separated into two wells: 25 ll A/Wyoming/03/2003 (H3N2) (TCID 50 = 10 8.49 ) was added to one well, the other was used as a control. Culture plates were incubated in a humidified atmosphere at 37°C in 5% CO 2 for 4 h, following surface staining for flow cytometry.
Virus titration
Madin-Darby Canine kidney (MDCK) cells were digested with 0.25% trypsin, washed with PBS, adjusted to 1 3 10 5 ml À1 in DMEM (Gibco Laboratories, Grand Island, NY, USA). Viruses were diluted sequentially in 0.002% trypsin DMEM. Hundred microliters of the virus and 100 ll MDCK cells were mixed into each well of a 96-well plate and incubated at 37°C in 5% CO 2 for 48 h. Hundred microliters of supernatant and 100 ll of washed chicken (0.5%) red blood cells were then mixed in a v-bottomed 96-well plate. The plates were kept at 4°C and read at 60 min. The aggregation of chicken red blood cells was as positive.
Virus labeling
Virus labeling followed the method described by Xie, 2009 (22) . In brief, 2.0 ll of 1 M sodium bicarbonate was added into 10 ll (100-500 lg) of purified virus and mixed. Fluorescent dyes including Cyanine (Cy3, Amersham), Cy5 (Amersham), PE (Dojindo Molecular Technologies, Inc.) and Allophycocyanin (Dojindo Molecular Technologies, Inc.) were dissolved in 3 ll of DMSO. Three microliters of fluorescent dye was added to the virus and mixed gently but thoroughly. The mixture of virus and dye was incubated in the dark for 1 h at room temperature. Added 6 ll of 4 M hydroxylamine to the mixture, mixed thoroughly and incubated for 15 min in the dark at room temperature. The mixture was then loaded on the top of a 1 ml G-50 column (Ambion Inc) and centrifuged at 750 3 g for 2 min. The dye-labeled virus ran through the 1.5 ml tube. Free dye was retained in the column matrix.
RNA preparation and reverse transcription-PCR
The mRNA expression levels of GrB were measured by reverse transcription-PCR in human enriched monocytes with and without virus-stimulated human PBMC using GAPDH as a control. Human GrB primers were 5#-AAGACGACTTCG-TGCT-3# and 5#-CAGATTCGCACTTTCGATC-3#. Primers to the human housekeeping gene, GAPDH, were 5#-GTCGGA-GTCAACGGAT-3# and 5#-CCACGACGTACTCAGC-3#. Toll-like receptor (TLR)3 primers were 5#-AACGACTGATGCTCCG-3# and 5#-TGGCCCGAAAACCTTC-3#. TLR4 primers were 5#-ACGTCTTGCCTATAAGCT-3# and 5#-GGTACAGGGGAGG-GAT-3#. Total RNAs were prepared with Qiagen RNeasy Mini Kit. One microgram total RNA per sample was used for the reverse transcriptions (Bio-Rad iScript cDNA Synthesis Kit) followed by 35 cycles of PCR (Bio-Rad SYBR Green PCR Kit) and detection on Bio-Rad iCycler. 
Isolation of monocytes, DC and plasma cells
Cell number changes calculation
Human PBMC 2.0 3 10 6 cells ml À1 of AIM-V media were stimulated with virus, viral protein (0.1 lg ml À1 ) and LPS (1 lg ml À1 ) for 20 h. All collected cells were re-suspended in 1 ml PBS and counted by Cell Counter (Beckman). Cell number changes ratios were calculated by the formula:
Cell number change = cell number of experimentÀcell number of control cell number of control %
Statistics
Data analyses were performed using SAS 9.1 (SAS Institute Inc.). The mean and standard error were used to describe the samples. Significant differences were assessed using a Student's t-test or the paired t-test. All tests were two sided and were reported as significant at the 95% level of confidence. Information on study participants was compiled only after all experiments were completed and the data were prepared for analysis. 
Results
Cell-mediated immune responses to virus infection
CD62L
high population of total PBMC was especially drastic because only sparse spots of GrB + CD62L high cells were observed in unstimulated PBMC (Fig. 1A) . Of all GrB + cells, there were only 10-20% GrB + CD8 + T cells (Fig. 1B) . At closer inspection, all GrB + cells were also Perf + (Fig. 1C) . These results suggested that the human cell-mediated immune response to influenza virus infection might be multi-sourced and only 1/10 to 1/5 of GrB + cells were CD8 + T cells.
GrB + CD62L high cells were fast response population to virus infection
Since there was a higher auto fluorescence in the activated monocytes and lymphocytes, especially at the late phase of the response (after 3 days), dissecting the early response would illustrate more accurate behaviors of monocytes and lymphocytes in virus infection. In order to appraise early cell-mediated immune responses to influenza virus infection, human PBMC were stimulated with influenza virus A/Wyoming/03/2003 (H3N2) for 2 h and stained with fluorescencetagged anti-CD62L, -CD3, -CD8 and GrB antibodies. Virus stimulation produced ;2-fold increase in the percentage of GrB + CD62L high/low cells of total PBMC. The proportion of GrB + CD62L high cells increased 4-fold as compared with the control group without virus stimulation ( Fig. 2A) . Virus stimulation also produced an increase of the CD3 signal in the population of monocytes/plasma cell by increasing the percentage of this population from 17.7 to 31.2% (Fig. 2B) . Most of monocytes/plasma were GrB + and CD62L low on the surface, whereas most CD3 + T cells were CD62L high . GrB + CD62L high CD3 + T cells quickly occurred and increased after virus stimulation (Fig. 2C) .
Compared with control, virus stimulation produced a 5-to 10-fold increase of GrB + CD62L high CD3 + T cells (N = 4, P < 0.001) and 1-fold of GrB + CD62L low monocytes cells (N = 4, P < 0.001). However, the absolute number of GrB + CD62L low cells were ;2-fold over GrB + CD62L high CD3 + T cells ( Fig. 2D and E) . These results suggested that GrB + CD62L high CD3 + T cells were the fast response population of T cells, whereas monocytes might be the long-term cytolytic population and the first line of defense.
Virus stimulation produced the increase of GrB expression in monocytes (CD14 + ), monocytes had cytolytic function
As mentioned above, monocytes expressed GrB and might have cytolytic function. To confirm these finding, human PBMC were stimulated with virus A/Wyoming/03/2003 (H3N2) for 2 h, followed by staining with anti-CD14 (monocytes marker) and GrB antibodies (Fig. 3A) . Virus stimulation for 2 h produced >2-fold increase of GrB expression in CD14 + cells. Do monocytes have cytolytic function? The cumulative exposure of granular membrane proteins (CD107a and b) on the cell surface of responding antigen-specific T cells provides a positive marker of degranulation (23) and the expressions of CD107a and b are consistent with GrB expression (24) . Human PBMC were stimulated with virus A/ Wyoming/03/2003 (H3N2) and incubated with anti-CD107a antibody for 2 h, followed by staining with anti-CD14 antibody. With virus stimulation, CD14
+ cells shifted toward surface CD107a
+ compared with unstimulated PBMC (Fig. 3B ). These results showed that virus infection caused the degranulation of CD14 + cells. Virus re-challenging also caused the degranulation of CD14 + cells again in human PBMC stimulated with virus for 5 days (data not shown).
Enriched monocytes were stimulated with influenza virus A/Wyoming/03/2003 (H3N2) for 20 h and GrB expression was measured by real-time reverse transcription-PCR. Virus stimulation greatly enhanced the expression of GrB by >80-fold as compared with control (N = 14, P < 0.0001; Fig.  3C ). All known TLRs expressions from TLR1 to TLR11 were also compared. Among all detected TLRs, the expressions of TLR3 (virus RNA receptor) and TLR4 (virus protein receptor) significantly increased by 40-and 8-fold, respectively (N = 14, P < 0.0001; Fig. 3D and E) . The copy number ratio of GrB/GAPDH was ;300000:1, whereas the ratios of TLR3 or TLR4/GAPDH were below 1400:1 after virus stimulation. The absolute expression of GrB was the highest as compared with all TLRs. These results proved that monocytes expressed GrB and influenza virus stimulation greatly enhanced its expression.
Previous work has built a new cytolytic assay method that used fluorescence-labeled virus to infect cells as target, used effector to attack target and evaluate the cytolytic activity of effector by flow cytometry (22, 25) . Enriched monocytes with or without virus stimulation had very strong cytolytic function even at 1:20 (E:T) (Fig. 3F ). All these results confirmed that monocytes expressed GrB and had a cytolytic activity. cells (Fig. 4A) . Human PBMC stimulated with influenza virus were incubated with anti-CD107a antibody for 3 h followed by staining with anti-CD11c antibody. The results showed that virus infection caused the degranulation of CD11c + cells in fresh PBMC. Virus re-challenge caused the degranulation of CD11c
DC expressed GrB and had cytolytic function
+ cells again. The isolated DC from PBMC stimulated with virus A/Wyoming/03/2003 (H3N2) for 5 days killed virus-infected cells (Fig. 4D) . These results suggested that DC had cytolytic activity.
Plasma cells expressed GrB and had cytotoxic function
Recently, it has been reported that either CpG oligodeoxynucleotide or anti-B-cell receptor antibody results in enhanced production of functional GrB by B cells and that B cells gain cytolytic function (26) . Present data here showed that viral stimulation produced a significant increase in the GrB
+ population (N = 11, P < 0.001). Within 17 h, there was a 2-to 3-fold increase in the GrB + CD138 + CD19 + population ( Fig. 5A and B) . All GrB + CD138 + CD19 + cells were also Perf + CD62L high and could degranulate (data not shown). The isolated plasma cells could kill virus-infected cells (Fig. 5C ). These results verified that plasma cells also expressed GrB and had cytolytic activity.
Virus-infected immune cells are going to apoptosis
Since externalization of phosphatidylserine occurs in the earlier stages of apoptosis, staining with Annexin V is typically used in conjunction with a vital dye such as PI to allow for identification of early apoptotic cells (Annexin V+, PIÀ) and late apoptosis or dead cells that are both Annexin V+ and PI+ (27) (28) (29) (30) . We used influenza virus to infect human fresh PBMC and incubated with Annexin V-FITC and PI together. Figure 6 shows that influenza virus infection caused the apoptosis of some fresh human PBMC. The early apoptosis cells (Annexin-V + ) and late apoptosis cells (Annexin-V + and PI + ) increased with virus infection compared with PBMC without virus infection. The DNA fragment assay showed that DNA ladders occurred at 30 min post-infection and strong bands showed up at 2 h post-infection, which confirmed that the influenza virus infection caused DNA degradation in cells (Fig. 6B) .
We used 51 Cr to label fresh human PBMC, following infection with influenza virus in order to monitor the apoptosis caused by virus infection. The specific 51 Cr release increased with time after influenza virus infection (Fig. 6C ). There were statistically significant increases in the early apoptotic cells (Annexin-V + ) and late apoptotic cells (Annexin-V + and PI + ), even at the 4 h time point, compared with the control without virus infection (P < 0.001, N = 8; Fig. 6D ). All of these results confirmed that influenza virus infection caused the apoptosis of the infected cells in fresh human PBMC.
We further confirmed this observation by using influenza virus to re-challenge human PBMC stimulated with virus for 5 days and incubating with Annexin V-FITC and PI together. Mature (GrB + ) lymphocytes mainly taken up virus in human PMBC stimulated with virus for 5 days (Fig. 7A ) (22) . The early (Annexin-V + ) and late (Annexin-V + and PI + ) apoptotic cells increased with infection (Fig. 7B) . This result suggested that the apoptosis occurred again when human PBMC stimulated with the influenza virus for 5 days was re-challenged with virus. We further analyzed 50 individuals (age range 20-70). The results confirmed that the percentage of GrB + CD3 T cells in the group with virus rechallenge were significantly lower than that in the control without virus re-challenge (pair t-test, P < 0.01, N = 50; Fig. 7D ).
Since the GrB + population contains monocytes and mature lymphocyte effector populations, we wondered if there was something special about these cells that leads to apoptosis during influenza virus infection. We used influenza virus to infect human PBMC for 1 h, followed by staining with Annexin-V and combined with anti-CD3, -CD8, -CD4, -CD14 (for monocytes) and anti-CD19 and -CD138 (for B cells and plasma) antibodies. The results showed that influenza virus infection could cause all of them to undergo apoptosis. There was no specific target as shown in Fig. 8 . GrB + cells always show a higher background in most fluorescence channels of cytoflowmetry. This was why CD14 and CD138 cells showed a higher background in no virus group.
We used influenza virus and influenza viral proteins to treat human PBMC, with untreated PBMC as the control. We collected whole cells at 20 h, counted cells with Cell Counter and calculated cell number changes in percentage. At 20 h, all recoveries of total white blood cells (WBC), lymphocytes and monocytes were negative, but the number changes of granulocytes increased greatly in all three groups (Fig. 8D) . The granulocytes gated by Cell Counter actually included mature lymphocytes and monocytes. PBMC stimulated with flagellin (Bacillus subtilis), viral proteins and LPS (Escherichia coli ) showed similar responses to that of virus stimulation. These results, especially the negative number changes of WBC, strongly proved that the antigen-caused apoptosis, involving the degranulation of GrB + cells, might also exist in the interaction between another antigen and the immune system cells.
Discussion
It is generally thought that influenza virus can be controlled by CD8 T cells or by antibodies (6, 12) . The contribution of innate immune system to virus infection remains unclear. The data presented in this paper showed that the cellmediated cytolytic cells were multi-sourced. Activated T, B cells and monocytes expressed GrB, gained cytolytic function and contributed to anti-virus activity. Since previous studies did not track early stage of immune response to virus stimulation and could not distinguish cytolytic cells from other memory cells, it might be the reason why it was thought that only CD8 T cells mainly contribute to the control of virus infection. This study showed that lymphocytes are fast response population to virus infection, and monocytes representing the long-term cytolytic population. All human PBMC had the ability to develop to cytolytic cells once they were activated.
Recently, there is much debate about how the CD62L high T CM and CD62L low T EM subsets relate to each other (14) (15) (16) (17) . By tracking very early response of human PBMC to virus infection with GrB antibody, activated (GrB + ) and inactivated (GrB À ) lymphocytes expressed higher surface CD62L than monocytes (CD62L low ). Since monocytes showed CD62L
low and almost of all T and B cells including activated T cells and plasma cells were CD62L high , through tracking very early response to viral stimulation, we think that traditional 'CD62L low T EM ' population might be the activated monocytes.
Virus stimulation also produced an increase of the CD3 signal in the population of monocytes/plasma cell (Fig. 2B) , which might be caused by that either these cells expressed CD3 or there was a higher auto fluorescence in activated monocytes/plasma cells.
Influenza virus could directly activate all types of cytolytic cells in vitro, which suggest that activation of cytolytic cells could quickly happen at infection site, such as the lung.
Virus stimulation simultaneously provoked the response of both the innate and adaptive immune system. Hence, innate and adaptive immune system worked together when the infection happened. It never occurs with the innate immune system single-handedly first defending the body, whereas the adaptive immune system waits for it to fail, as 'the infection cannot be resolved by innate immunity, which trigger an adaptive immune response and are then overcome successfully, followed by lasting immunological memory' (3).
Recently, there have been reports that influenza A and B viruses induce apoptosis in a variety of cell types (including macrophages) both in vitro and in vivo (31) (32) (33) . It was thought that apoptosis was primarily a host defense mechanism, limiting virus replication and that influenza virus overcame this by rapid multiplication before apoptosis was induced (34) . However, there is evidence that induction of apoptosis is essential for replication and propagation (35) . Efficient viral mRNA (vmRNA) synthesis has also been shown to correlate with apoptosis induction (36) . Those conflicting results might be due to the experimental conditions used. For instance, virus induced apoptosis in MDCK and other non-lymphocyte cell lines should be different from that in PBMC. Influenza virus simulation in MDCK showed that most virions were attached to the cellular membrane within 2-5 min post-infection. By 15-20 min post-infection, all virions have entered the cell. As soon as the first viral ribonucleoproteins reach the nucleus at ;30 min post-infection, vmRNAs are being transcribed in high copy number. The switch from vmRNA production to virus genome replication takes place ;3 h post-infection. Approximately 5 h postinfection, newly produced virus particles are released into the extracellular medium (37) . The cytopathic effect in MDCK cells caused by influenza virus might be similar to that of the respiratory tract epithelial cells of lung infected with influenza virus and might be due to fast replication of the virus that exhausts the host resources; therefore, its cytopathic effect is usually checked after 24 h. Dynamic analysis of the interaction between PBMC and influenza virus with Annexin-V and anti-CD107b antibody showed that the increase in apoptotic cells and the GrB release (degranulation) start within 5 min post-infection (22) . It is hard to imagine that the apoptotic cells in PBMC are linked to virus replication because the traditional view states that virus processing must occur in order that viral peptides be presented on the cell surface, which can be recognized by the cytotoxic cells. We also collected the supernatants at 1, 2, 3 and 5 days postinfection and used these to infect MDCK cells, but we failed to get a virus titer. Because the cytopathic response caused by virus replication in the MDCK and respiratory tract epithelial cells is different from the apoptosis in virus-infected PBMC, the apoptosis of the virus-infected cells in human PBMC is the means of combating virus infection.
We found that PBMC stimulated with one of the A type virus strains could kill the cells infected with another A type strain, even a B type virus. This cytotoxicity showed low specificity. Apoptosis of cells occurred regardless of which strain of virus infected the human PBMC. Our results showed that most cells of PBMC infected with virus were killed within 2 h. Early studies did not recognize that cytotoxicity plays a role in the apoptotic cells induced by influenza virus (23, 31, 32) . Therefore, the apoptosis of virus-infected cells including immune and non-immune cells (such as epithelium of lung) could be directly and non-specifically killed by GrB + cells over time instead of waiting for viral antigen presented on the surface. This could be an important mechanism of the human immune system in combating virus infection. Since there is a potential for substantial overlap in phenotypic and functional characteristics between NK and DCs (38) . Another mechanisms might be the phagocytosis and antibody and complement-mediated killing. The antibody and complement-mediated killing might be very weak because our assay used sera-free AIM-V as culture medium.
Based on our results and as discussed above, we propose the pathological mechanism of influenza virus infection and immune system responses. If influenza viruses enter the respiratory tract and overwhelm the humoral defense system because of poor antibodies or virus mutation, viruses will infect respiratory tract epithelial cells and immune effector cells. If there are only a few virus particles or if there are enough GrB + cells, the cells infected with virus are directly killed over time. In this case, virus infection will be limited. Signals released by infected cells may cause the inflammation reaction to over-compensate for those dead cells. On the contrary, if there are few immune effector cells, virusinfected cells won't be killed in time and virus will replicate in epithelial cells and release more virus particles, which causes more epithelial cells to become infected with virus and finally exhaust more epithelial cells. This also leads to exhausting of most immune system functional cells and may destroy the human primary line of defense. We used the virus of various MOI from 2 to 2000 to infect human PBMC. Within 200 of MOI, most people showed no significant change in WBC loss at 20 h. At up to 2000 of MOI, there was a huge drop of total WBC at 20 h in some people's PBMC, but not for all. This might be analogous to the chemical buffer solution; once its capacity is overwhelmed, the pH value cannot be maintained any longer. The greater number of infected cells will prompt a stronger inflammatory reaction. Before compensation of all exhausted immune functional cells, the secondary infection of bacteria or virus will occur. Or if many viruses enter the respiratory tract, viruses may infect the epithelial cells and exhaust all immune functional cells. Bacteria will grow and cause the secondary infection before the immune response rebuilds. Since bacteria will also consume immune system cells as mentioned above, secondary infection of bacteria will delay rebuilding of the immune response and make the condition worse. The extreme situation might be that whole immune system rebuilding in the lung is overwhelmed due to virus fast replication or poor immune cells, causing serious secondary infection and exhausting all epithelial cells, finally leading to the loss of lung function. The mechanism of this interaction between influenza virus and the immune system can explain the reasons why the clearance of influenza virus infection correlates with cytotoxic activity in past reports (39) and why antibodies have limited ability protect from influenza virus infection.
Once viruses overcome this first line of defense, the infection can facilitate the secondary infections. Influenza virus may further infect other tissue types, such as brain cells. There are several reports that influenza virus caused encephalopathy and apoptosis is a possible pathogenesis (40, 41) . Therefore, in clinical treatment, we strongly suggest that antibiotics should be used immediately in high-risk persons such as seniors and those with underlying medical conditions, such as cardiovascular or respiratory disease, and children <5 years of age once they were found or suspected to be infected by influenza virus, especially during flu season. Another option is to find a way to enhance the immune system function, e.g. increase immune system functional cell number in the peripheral tissue, such as lung. It is generally thought that pathogenicity is dependent on the particular strain, which might be understood as two aspects: one is that many people already have antibodies against this strain that can limit this strain infection. On the other hand, a milder virus might slowly replicate; therefore, the immune system has plenty of time to recruit enough activated cells to remove virus.
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